Abstract
We have reported that noncytotoxic concentrations of 3′-azido-3′-deoxythymidine (AZT) increase the cytotoxicity of ICI Dl694, a folate-based thymidylate synthase (TS) inhibitor, with increasing AZT incorporation into DNA. We postulated that the inhibition of TS by ICI D1694 would decrease 5′-deoxythymidine triphosphate (dTTP) pools, which compete with AZT triphosphate (AZT-TP) as a substrate for DNA polymerase. Furthermore, the inhibition of TS would increase the activity of both thymidine kinase (TK) and thymidylate kinase (TdK). Each of these consequences of TS inhibition would favor more incorporation of AZT into DNA. Thus, we reasoned that other TS inhibitors should also result in increased AZT incorporation into DNA and, perhaps, in increased cytotoxicity. N 6-[4-(Morpholinosulfonyl) benzyl]-N 6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) differs from ICI D1694 in that it is a de novo designed lipophilic TS inhibitor, it does not require a specific carrier for cellular uptake, and it does not undergo intracellular polyglutamation. This potent TS inhibitor causes minimal cytotoxicity in MGH-U1 human bladder cancer cells. A 24-h exposure to 5 μM AG-331 causes almost complete TS inhibition but only 35% cell kill. The combination of AZT and AG-331 in MGH-U1 cells resulted in an enhanced antitumor effect relative to that of each agent alone; 50 μM AZT, noncytotoxic alone, increased the cell kill of induced by AG-331 from 35% to 50%. Biochemical studies of this combination revealed that simultaneous treatment with 5 μM AG-331 plus 1.8 μM [3H]-AZT produced as much as a 68% ± 7% increase in AZT incorporation into DNA. This observation was associated with an increase in DNA single-strand breaks, measured as comet tail moment, of up to 6.6-fold. These studies support our original premise that TS inhibition favors increased incorporation of AZT into DNA and that the combination causes more cell kill than either drug alone in MGH-U1 cells.
Similar content being viewed by others
Abbreviations
- AZT:
-
3′-Azido-3′-deoxythymidine
- TS:
-
thymidylate synthase
- dTTP:
-
5′-deoxythymidine triphosphate
- AZT-TP:
-
AZT triphosphate
- TK:
-
thymidine kinase
- TdK:
-
thymidylate kinas
- AG-331:
-
N 6-[4-(morpholinosulfonyl)benzyl]-N 6-methyl-2,6-diaminobenz[cd]indole glucuronate
- dTMP:
-
thymidylate
- TdR:
-
thymidine
References
Danenberg PV (1977) Thymidylate synthetase: a target enzyme in cancer chemotherapy. Biochim Biophys Acta 473: 73
Houghton JA, Houghton PJ, Woonten RS (1979) Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine and 5-fluoro-2′-deoxyuridine. Cancer Res 39: 2406
Weber G (1983) Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture. Cancer Res 43: 3466
Pressacco J, Erlichman C (1993) Combination studies with 3′-azido-3′-deoxythymidine (AZT) plus ICI D1694: cytotoxic and biochemical effects. Biochem Pharmacol 46: 1989
Darnowski JW, Goulette FA (1993) Increased azido-deoxythymidine metabolism in the presence of fluorouracil reflects increased thymidine kinase activity. Proc Am Assoc Cancer Res 34: 302
Jones TR, Varney MD, Webber SE, Welsh KM, Webber S, Matthews DA, Appelt K, Smith WS, Janson C, Bacquet R, Lewis KK, Marzoni GP, Kathardekar V, Howland E, Booth C, Herrmann S, Ward R, Sharp J, Moomaw E, Bartlett C, Morse C (1990) New lipophilic thymidylate synthase inhibitors designed from the X-ray structure of the E. coll enzyme. Proc Am Assoc Cancer Res 31: 340
Nicander B, Reichard P (1983) Dynamics of pyrimidine deoxynucleoside triphosphate pools in relationship to DNA synthesis in 3T6 mouse fibroblasts. Proc Natl Acad Sci, USA 80:1347
Erlichman C, Vidgen D (1984) Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids and xenografts in immune-deprived mice. Cancer Res 44: 5369
Mackillop WJ, Stewart SS, Buick RN (1982) Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma. Br J Cancer 45: 812
Chu M-Y, Fischer GA (1968) The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). Biochem Pharmacol 17: 553
Olive PL, Banath JP, Evans HH (1993) Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging. Br J Cancer 67: 522
Olive PL, Banath JP, Durand RE (1990) Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the “comet” assay. Radiat Res 122: 86
Tosi P, Calabresi P, Goulette FA, Renaud CA, Darnowski JW (1992) Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. Cancer Res 52: 4069
Frick LW, Nelson DJ, St Clair MH, Furman PA, Krenitsky TA (1988) Effects of 3′-azido-3′-deoxythymidine on the deoxynuc-leotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154: 124
Sommadossi J-P, Carlisle R, Zhou Z (1989) Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 36:9
Vazquez-Padua MA, Starnes MC, Cheng Y-C (1990) Incorporation of 3′-azido-3′-deoxythymidine into cellular DNA and its removal in a human leukemic cell line. Cancer Commun 2:55
Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW (1986) Phosphorylation of 3′-azido-3′-deoxy-thymidine and selective interaction of 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333
Pressacco J, Hedley DW, Hu Q, Chow S, Newcombe D, Erlichman C (1994) D1694 biochemical modulation of idoxuridine (IUDR) causes synergistic cytotoxicity. Proc Am Assoc Cancer Res 35: 326
Mitrovski B, Johnston PG, Erlichman C (1994) Cytotoxic and biochemical effects of a lipophilic (AG-331) and a non-lipophilic (D1694) thymidylate synthase inhibitor in MGH-U1 cells. Proc Am Assoc Cancer Res 35: 300
Author information
Authors and Affiliations
Additional information
Supported by a grant from the NCI (Canada)
Rights and permissions
About this article
Cite this article
Pressacco, J., Mitrovski, B. & Erlichman, C. Cytotoxic and biochemical implications of combining AZT and AG-331. Cancer Chemother. Pharmacol. 35, 387–390 (1995). https://doi.org/10.1007/s002800050251
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002800050251